Calculation
P/BV | = | Share price1, 2, 3 | ÷ | Book value per share1 (BVPS) | BVPS1 | = | Total Biogen Inc. shareholders’ equity1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 3, 2022 | 2.97 | = | 220.17 | ÷ | 74.14 | 74.14 | = | 10,896,200 | ÷ | 146,962,793 | |
Feb 3, 2021 | 3.75 | = | 263.25 | ÷ | 70.24 | 70.24 | = | 10,700,300 | ÷ | 152,335,731 | |
Feb 6, 2020 | 4.40 | = | 337.24 | ÷ | 76.66 | 76.66 | = | 13,343,200 | ÷ | 174,064,011 | |
Feb 6, 2019 | 5.03 | = | 333.24 | ÷ | 66.29 | 66.29 | = | 13,039,600 | ÷ | 196,708,784 | |
Feb 1, 2018 | 5.80 | = | 346.00 | ÷ | 59.62 | 59.62 | = | 12,612,800 | ÷ | 211,562,686 | |
Feb 2, 2017 | 4.70 | = | 264.23 | ÷ | 56.22 | 56.22 | = | 12,140,100 | ÷ | 215,951,945 | |
Feb 3, 2016 | 6.31 | = | 270.43 | ÷ | 42.86 | 42.86 | = | 9,372,800 | ÷ | 218,672,717 | |
Feb 4, 2015 | 8.49 | = | 391.12 | ÷ | 46.07 | 46.07 | = | 10,809,010 | ÷ | 234,614,474 | |
Feb 6, 2014 | 8.25 | = | 301.01 | ÷ | 36.47 | 36.47 | = | 8,620,242 | ÷ | 236,393,930 | |
Feb 5, 2013 | 5.34 | = | 157.36 | ÷ | 29.46 | 29.46 | = | 6,961,523 | ÷ | 236,312,191 | |
Feb 3, 2012 | 4.53 | = | 121.88 | ÷ | 26.92 | 26.92 | = | 6,425,499 | ÷ | 238,725,065 | |
Feb 4, 2011 | 2.94 | = | 65.93 | ÷ | 22.40 | 22.40 | = | 5,396,506 | ÷ | 240,911,883 | |
Feb 9, 2010 | 2.34 | = | 54.09 | ÷ | 23.08 | 23.08 | = | 6,221,530 | ÷ | 269,601,262 | |
Feb 6, 2009 | 2.69 | = | 52.48 | ÷ | 19.53 | 19.53 | = | 5,806,083 | ÷ | 297,252,825 | |
Feb 14, 2008 | 3.38 | = | 62.87 | ÷ | 18.59 | 18.59 | = | 5,534,295 | ÷ | 297,750,601 | |
Feb 21, 2007 | 2.25 | = | 47.02 | ÷ | 20.88 | 20.88 | = | 7,149,778 | ÷ | 342,436,836 | |
Mar 3, 2006 | 2.27 | = | 45.50 | ÷ | 20.07 | 20.07 | = | 6,905,876 | ÷ | 344,098,779 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Biogen Inc. Annual Report.
Comparison to Competitors
Biogen Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb 3, 2022 | 2.97 | 16.53 | 18.51 | 4.07 | 4.16 | 25.28 | 3.65 | 5.90 | 5.05 | 4.31 | 3.35 | 3.60 | 5.18 |
Feb 3, 2021 | 3.75 | 14.18 | 14.53 | 3.55 | 3.93 | 35.07 | 4.33 | 6.72 | 7.46 | 24.16 | 2.98 | 4.81 | 5.15 |
Feb 6, 2020 | 4.40 | — | 13.84 | 2.80 | 3.72 | 51.67 | 3.93 | 6.61 | 7.83 | 8.21 | 3.00 | 3.79 | 4.16 |
Feb 6, 2019 | 5.03 | — | 9.41 | 5.89 | 2.80 | 12.87 | 3.89 | 6.08 | 7.79 | 4.29 | 3.80 | 5.07 | 3.75 |
Feb 1, 2018 | 5.80 | 36.95 | 5.02 | 8.88 | 2.58 | 7.33 | 5.15 | 5.79 | 4.30 | — | 2.94 | 5.66 | 3.30 |
Feb 2, 2017 | 4.70 | 21.24 | 4.14 | 5.66 | 2.56 | 6.33 | 4.88 | 4.72 | 4.51 | — | 3.40 | 8.58 | 2.86 |
Feb 3, 2016 | 6.31 | 22.17 | 3.94 | 7.04 | 2.53 | 5.51 | 6.59 | 4.07 | 3.15 | — | 2.84 | 10.53 | 2.42 |
Feb 4, 2015 | 8.49 | 56.09 | 4.59 | 6.72 | 2.63 | 5.14 | 10.08 | 4.01 | 3.42 | — | 2.95 | 16.22 | 2.51 |
Feb 6, 2014 | 8.25 | 18.05 | 4.30 | 5.92 | 2.38 | 3.69 | 11.36 | 3.50 | 3.35 | — | 2.69 | 16.74 | 2.90 |
Feb 5, 2013 | 5.34 | 18.06 | 3.57 | 4.40 | 2.23 | 4.15 | 7.01 | 3.29 | 2.44 | — | 2.42 | 12.91 | 1.72 |
Feb 3, 2012 | 4.53 | — | 2.83 | 3.50 | 2.17 | 3.35 | 5.08 | 3.13 | 2.14 | — | 1.95 | 19.19 | 1.38 |
Feb 4, 2011 | 2.94 | — | 2.04 | 2.76 | 2.39 | 3.21 | 5.29 | 2.88 | 1.85 | — | 1.75 | 6.42 | 1.41 |
Feb 9, 2010 | 2.34 | — | 2.46 | 2.88 | 2.07 | 4.17 | 6.74 | 3.45 | 1.97 | — | 1.57 | 5.49 | 1.29 |
Feb 6, 2009 | 2.69 | — | 2.48 | 3.29 | 1.69 | 5.01 | 9.83 | 3.56 | 2.72 | — | 1.44 | 2.94 | 1.02 |
Feb 14, 2008 | 3.38 | — | 2.77 | 4.22 | 2.62 | 4.16 | 11.76 | 4.17 | 5.38 | — | 2.32 | 3.24 | 1.62 |
Feb 21, 2007 | 2.25 | — | 3.96 | 5.50 | 3.32 | 5.43 | 18.07 | 4.78 | 5.45 | — | 2.49 | 5.77 | 1.38 |
Mar 3, 2006 | 2.27 | — | 4.26 | 4.00 | 3.78 | 5.85 | 9.18 | 4.66 | 4.30 | — | 2.94 | 8.16 | 2.03 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Biogen Inc., P/BV, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
Biogen Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
---|---|---|
Feb 3, 2022 | 2.97 | 5.66 |
Feb 3, 2021 | 3.75 | 6.13 |
Feb 6, 2020 | 4.40 | 5.74 |
Feb 6, 2019 | 5.03 | 5.93 |
Feb 1, 2018 | 5.80 | 5.04 |
Feb 2, 2017 | 4.70 | 4.52 |
Feb 3, 2016 | 6.31 | 4.10 |
Feb 4, 2015 | 8.49 | 4.40 |
Feb 6, 2014 | 8.25 | 3.93 |
Feb 5, 2013 | 5.34 | 3.19 |
Feb 3, 2012 | 4.53 | 2.53 |
Feb 4, 2011 | 2.94 | 2.23 |
Feb 9, 2010 | 2.34 | 2.35 |
Feb 6, 2009 | 2.69 | 2.58 |
Feb 14, 2008 | 3.38 | 3.41 |
Feb 21, 2007 | 2.25 | 3.81 |
Mar 3, 2006 | 2.27 | 3.98 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Biogen Inc. | Health Care | |
---|---|---|
Feb 3, 2022 | 2.97 | 4.78 |
Feb 3, 2021 | 3.75 | 4.66 |
Feb 6, 2020 | 4.40 | 4.41 |
Feb 6, 2019 | 5.03 | 4.42 |
Feb 1, 2018 | 5.80 | 4.25 |
Feb 2, 2017 | 4.70 | 3.83 |
Feb 3, 2016 | 6.31 | 3.47 |
Feb 4, 2015 | 8.49 | 3.90 |
Feb 6, 2014 | 8.25 | 3.30 |
Feb 5, 2013 | 5.34 | 2.70 |
Feb 3, 2012 | 4.53 | 2.38 |
Feb 4, 2011 | 2.94 | 2.11 |
Feb 9, 2010 | 2.34 | 2.23 |
Feb 6, 2009 | 2.69 | 2.42 |
Feb 14, 2008 | 3.38 | 3.26 |
Feb 21, 2007 | 2.25 | 3.75 |
Mar 3, 2006 | 2.27 | 3.89 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).